Your Patients Are Already Asking About Peptides. Give Them an Answer Grounded in Evidence, Not Social Media.
The IAPAM Peptide Therapy in Clinical Practice course gives you an evidence-based framework for evaluating GLP-1 and GIP therapies, growth hormone secretagogues, and regenerative peptides β so you can counsel patients accurately, source and document responsibly, and stay current on a regulatory landscape that's still being written.
Peptide Therapy for Healthcare Providers
Special Introductory Price until August 31: Only $295! (Reg. $595. Save $300!)
Price will raise to $395 starting September 1.Β
What You'll Learn
- Differentiate FDA-approved peptide therapies from compounded, investigational, and research-use-only products β and know which category each commonly requested peptide falls into.
- Evaluate GLP-1 and dual GIP/GLP-1 therapies (semaglutide, tirzepatide, liraglutide) by mechanism, approved indication, and patient fit.
- Apply current 503A/503B sourcing rules and recognize red flags for gray-market and research-use-only products before they reach your patients.
- Review growth hormone secretagogues β sermorelin, tesamorelin, CJC-1295, ipamorelin, MK-677 β including their evidence base, dosing considerations, and regulatory status.
- Assess regenerative peptides including BPC-157, TB-500, and GHK-Cu, and separate mechanistic plausibility from proven clinical outcomes.
- Build a documentation-ready informed consent and monitoring framework for peptide therapy in your practice.
- Structure consultation pricing, cash-pay protocols, and compliant marketing for a peptide program.
You'll have 12-months of access to complete this course. This includes any updates we make to your program during this time.Β
This course comes with a Certificate of Completion. Simply complete the assessment at the end of the course and your certificate is automatically emailed to you. Double check your spam/junk folder if you do not see the email within 30-60 minutes.
Evidence Over Hype
Distinguish FDA-approved therapies from compounded, investigational, and research-use-only products your patients are already asking about.
One Course, Two Markets
Peptide therapy spans aesthetics and medical weight loss β the clinical framework applies regardless of which side of your practice is growing faster.
Regulatory Literacy Protects Your License
503A/503B sourcing rules, FDA safety-risk designations, and informed consent β covered before you prescribe or discuss peptides with a patient.
